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1 Abbreviations used in the article: GD = gestational diabetes 
Abstract 
Aims. The aim of this study was to determine the prevalence of diabetes among women 
5 years after having gestational diabetes during pregnancy. Also, we sought to 
determine whether women who develop diabetes after GD during pregnancy differ from 
women who do not develop diabetes after GD during pregnancy. 
Methods. This longitudinal study was performed using data from medical birth 
certificates and CroDiab diabetes registry. Women burdened with gestational diabetes in 
Croatia in 2011 were followed up until year 2016. Those registered in CroDiab registry 
were recognised as new patients with diabetes. 
Results. Among 40641 deliveries in 2011, gestational diabetes was reported in 1181 
(2.9%) women. Among them 853 (72.23%) were followed up in CroDiab diabetes 
registry and 32 (3.75%) were identified as new patients with diabetes. Median time from 
childbirth to onset of diabetes was 29.12 months. The diabetes group did not 
significantly differ to the group without diabetes according to age (p=0.587), level of 
education (p=0.549) or marital status (p=0.849) except that the diabetes group was 
significantly more obese than the group without diabetes (p=0.002). 
Conclusions. Based on CroDiab diabetes registry data prevalence of diabetes 5 years 
after pregnancy complicated with gestational diabetes is 3.75% in Croatia. Women with 
gestational diabetes during pregnancy, and especially those with higher BMIs, are an 
important risk group for developing diabetes later in life so screening and preventive 
measures should be oriented toward them in primary care settings. 
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Introduction 
Gestational diabetes (GD) is a common pregnancy-related condition diagnosed in 
almost 5% of all pregnancies in Croatia (1). It presents an important risk factor for 
adverse perinatal outcomes including induction of labour and caesarean section, as well 
as certain serious short and long-term consequences to both mother and new-born (2). 
GD is related to a higher risk of neonatal hypoglycemia, hyperbilirubinemia, 
hypocalcaemia, polycythemia and respiratory distress as well as excessive fetal growth 
leading to macrosomia (3,4). These risks can be minimized with medical nutritional 
therapy and good glycemic control (5). 
Children born to mothers with GD are more likely to be overweight at an early age and 
have an increased risk of type 2 diabetes and pre-diabetes in adult childhood compared 
to children born to mothers without GD (6,7). On the other hand, women burdened with 
GD during pregnancy are at risk of developing diabetes later in life. Studies have 
reported that women with GD during pregnancy have a seven to twelve times (8-10) 
higher risk of developing type 2 diabetes compared with women who are 
normoglycaemic during pregnancy and, according to a systemic literature review by Kim 
et al. (11), the occurrence rate is highest in the first 5 years after pregnancy. This 
systemic review also revealed a wide range of cumulative incidence of diabetes ranging 
from 2.6% to over 70%, which is presumably due to different follow-up periods among 
studies expanding from 6 weeks to 28 years postpartum. Specifically, the rate of 
development of diabetes after GD was almost 14% by 11 years after delivery in Spain 
(12) and almost 20% by 9 years after delivery in a study performed in Canada (13).  
In a recent meta-analysis by Rayanagoudar et al. (14), advanced maternal age, BMI and 
family history of diabetes were associated with future risk of type 2 diabetes, 
accentuating the importance of personalised risk of progression to type 2 diabetes in 
each pregnant woman. A study by Bian et al. (15) came to similar conclusions, where 
two or more abnormal OGTT values during pregnancy and high BMI of pregnant women 
were risk factors for developing diabetes later in life. However, similar studies for 
populations in Southeast Europe are scarce and there is limited data on the long-term 
maternal consequences of GD. This prevents full comprehension of the relevance and 
importance of this condition and its possible future effect on diabetes prevalence. 
The aim of this study was to reveal the risk of developing diabetes after GD by 
determining the prevalence of diagnosed diabetes in women 5 years after having GD 
diagnosed in pregnancy in Croatia. Also, we sought to determine the difference in 
occurrence of risk factors which might predispose women to develop diabetes after 
having GD during pregnancy. 
 
Methods 
This retrospective longitudinal study was performed using data from medical birth 
certificates (MBC) collected in Croatia as part of perinatal statistics data collection and 
data from the CroDiab diabetes registry; a registry gathering data on all patients 
diagnosed with diabetes in Croatia (16, 17). Both of these registries are reported to the 
Croatian Institute of Public Health (CIPH) and are mandatory to complete; data for 
medical birth certificates are fulfilled by the birth attending doctor while data for the 
Crodiab diabetes registry is fulfilled by either general practitioners caring for patients 
with diabetes in primary care or by diabetologists. Data for CroDiab registry is collected 
from the databases of all primary health care prescriptions and patients diagnosis 
ensuring complete coverage of diagnosed persons with diabetes in Croatia. 
Women burdened with GD in 2011 were identified and followed up until year 2016. 
Those registered in CroDiab registry were recognised as new patients with diabetes. 
Also, the registry of deceased was searched in order to identify if any of the followed up 
women who did not have GD had died. The registry of deceased is part of CroDiab 
registry, so all women who developed diabetes after GD were included in the follow-up. 
In 2011, GD was diagnosed according to national guidelines published by the Croatian 
Society for Gynaecology and Obstetrics (18, 19) which are still in use today. These 
guidelines are based on the recommendation of the International Association of the 
Diabetes in Pregnancy Study Group (IADPSG) (20) and include performing a one-step 
75g OGTT test between 24 and 28 weeks for women not previously diagnosed with 
overt diabetes. GD is diagnosed if plasma glucose values meet or exceed fasting value 
≤ 5.1 mmol/L, 1-hour value ≤ 10.0 mmol/L and 2-hour value of ≤ 8.5 mmol/L. 
After identifying women who had GD during pregnancy in 2011 through medical birth 
certificates, several data were collected including age at the end of follow-up period in 
2016, body mass index (BMI) before pregnancy, level of education as well as marital 
status. Level of education was defined as: unfinished primary school and primary school, 
high school or similar and college, university and postdoc education, while marital status 
was considered as either married or living in a couple opposed to being single or 
divorced. Women with GD who were not followed up after childbirth due to lack of 
identification (ID) number were compared according to age and BMI to women who were 
followed up just in order to exclude major potential bias caused by loss to follow-up. 
Statistical analyses were performed using SAS Enterprise Guide ver. 7.1. Normality of 
distribution was tested using Shapiro-Wilks test, while homogeneity of variance was 
tested using Levene test. Differences between groups of independent continuous 
variables were analysed using t-test and Mann – Whitney U test while differences in the 
prevalence of individual conditions were compared using the chi (χ)2 test, with Yates 
correction when appropriate. Statistical significance was defined as p<0.05.  
Primary outcome of this study was to find out the prevalence of diabetes 5 years after 
pregnancy complicated with GD. Secondary outcomes were to determine whether age, 
level of education, marital status and pre-pregnancy obesity differ between women who 
develop diabetes after GD during pregnancy and women who do not develop diabetes 
after GD during pregnancy. 
Ethical approval was obtained from CIPH Ethical Committee for Health Researches, 
grant number 030-02/17-10/1. 
 
Results 
Among 40641 deliveries in Croatia in 2011; 1181 (2.9%) women were reported to have 
GD. Among these women, 853 (72.23%) were identified using ID numbers and followed 
up in CroDiab diabetes registry. None of them died during the follow up period and 32 
(3.75%) were identified as newly diagnosed patients with diabetes five years later. 
Median (Q1, Q3) age at the end of follow-up of women with GD who developed diabetes 
was 37 (33, 42) years while the comparable age was 36 (33, 40) for women with GD 
who did not develop diabetes. Median (Q1, Q3) BMI before pregnancy in the diabetes 
group was 26.96 (25.10, 31.56) and in the non-diabetes group 24.55 (21.72, 28.69). 
Women who developed diabetes and those who did not develop diabetes did not 
significantly differ according to age (p=0.587), level of education (p=0.549) or marital 
status (p=0.849) but women who developed diabetes were significantly more obese 
before pregnancy compared to the women who did not develop diabetes (p=0.002). 
Age at the end of follow up, BMI before pregnancy, level of education and marital status 
of women with GD who developed diabetes and women with GD who did not developed 
diabetes as well as differences between those two groups are presented in table 1. 
 
Table 1. Differences between women with GD who developed diabetes and women with 
GD who did not develop diabetes 
  Women with GD 
who developed 
diabetes 
Women with GD who 
did not develop diabetes 
p-
value 
Age at the end of follow up 
(years) * 
37 (33, 42) 36 (33, 40) 0.587 
BMI before pregnancy (kg/m2)* 26.96 (25.10, 31.56) 24.55 (21.72, 28.69) 0.002 
Level of education    0.549 
Up to finished primary school (%) 9.10 5.54 
High school and more (%) 77.27 72.51 
College and more (%) 13.63 21.95 
Marital status   0.849 
Un paired 
(unmarried, divorced, widow) (%) 
10.34 9.29 
Paired (married, cohabitation) (%) 89.66 90.71 
* Data are presented as median (first quartile Q1, third quartile Q3) 
The remaining 328 women who had GD in 2011 but were not followed-up in CroDiab 
diabetes registry due to lack of ID number were also analyzed. The results showed that 
these women did not differ significantly compared to followed up GD women concerning 
age (p=0.185) and BMI (p=0.914). 
The Kaplan-Meier estimation of the length of time (in months) until women who have 
had GD during pregnancy develop diabetes is presented on Figure 1. 
 
Figure 1. Time to diabetes development in women with gestational diabetes in Croatia 
who developed diabetes within five years of childbirth 
 
Discussion 
Based on available data in CroDiab diabetes registry, prevalence of diabetes 5 years 
after pregnancy complicated with GD is 3.75%. This result seems to be less compared 
to previously published studies and similar to only one other study from Sweden where 
diabetes prevalence was 3.4% among women 3-4 years after childbirth (21). The 
majority of other studies report higher prevalence rates, ranging from 14% (9) or 20% 
(13) by 11 or 9 years postpartum and up to 33.3% among women investigated 5-10 
years postpartum (15). We believe a longer period of follow up in the latter studies might 
be the cause of higher diabetes prevalence compared to the one observed in our study. 
Hence, we find it is difficult to compare our reported prevalence with other studies due to 
this different follow-up periods involved. Unfortunately, we were unable to perform such 
a long-term follow-up since good quality data on GD prevalence in Croatia exist from 
2011, while earlier data is not representable.  
Still, prevalence of gestational diabetes in 2011 reported in this study might be an 
underestimation as a result of underreporting in the registry of medical birth, mostly due 
to incomplete or inadequate filling in of data by doctors attending deliveries, which is 
supported in a report published in 2016 (22). Under diagnosis of the presence of GD in 
2011 should also be kept in mind affecting the results in our study. Year 2011 is the year 
of introduction of new national guidelines for diagnosis and management of GD, so 
gradual and steady implementation of these guidelines might be a cause of under 
diagnosis, notably since a better diagnosis and consequently better reporting trend was 
identified in the following years (22). 
Nevertheless, despite this weakness, our study demonstrates that women with GD 
during pregnancy are at increased risk of developing diabetes even as early as 5 years 
after delivery. Women with GD represent a high-risk population for development of 
diabetes later in life and should be followed up and monitored intensely after childbirth in 
their primary care setting. By performing regular preventive educative measures (i.e. 
accentuating the importance of a healthy, balanced diet as well as regular physical 
activity) these women can avoid or postpone developing diabetes later in life. This was 
confirmed in a randomized controlled trial published in 2008, where both intensive 
lifestyle and metformin were highly effective in delaying or preventing diabetes in women 
with a history of GD (23). Also, a recently published systematic review confirmed 
intervention to be superior to no intervention, but no specific intervention was shown to 
be superior to others (24). 
Additionally, a study by Claesson et al. showed that a third-trimester HbA1c value ≥ 
5.4% among women with GD could be used as a mean for selecting women at high risk 
of developing diabetes later in life (25). Target screening performed after delivery can 
identify the presence of diabetes in its earliest stage allowing the introduction of 
appropriate treatment. Health care practitioners in primary care play an essential role in 
this process since they possess a complete, continuous and long-term insight of 
women’s health condition.  
The majority of health authorities worldwide recommend postpartum screening of 
diabetes between 6 and 12 weeks after delivery (26, 27), but many women with GD 
during pregnancy do not undergo postpartum glucose testing (28). In most populations, 
only half of women with a history of GD are screened after childbirth (29). According to a 
study by Van Ryswyk et al. (30), three most common barriers for women to this include: 
not having enough time, inadequate childcare and a need to focus on the health of the 
baby. Health care professotionals also contribute to this, since a study by Shah et al. 
revealed that despite high rates of postpartum visits to family physicians and 
obstetricians, few women with GD received the recommended diabetes test (31). 
By pointing out the long-term sequels of GD during pregnancy, we believe women might 
be more motivated to attend early postpartum screening with all benefits it can provide. 
Likewise, a possible improvement of existing guidelines on postpartum management of 
gestational diabetes might be including an additional screening scheme one or two 
years after childbirth- a period when women have more time and focus more on their 
health but are still at risk of developing diabetes. Also, the importance of postpartum 
screening among women with GD should be accentuated both to pregnant women 
diagnosed with GD during pregnancy as well as primary care practitioners who are in 
charge of future health-related follow up of these women. Primary care practitioners 
should be more active in motivating and mobilizing their female patients to attend 
postpartum screening. This is supported by a systematic review by Carson et al. (32), 
where proactively contacting patients via phone calls, education programs or postal 
reminders was associated with higher postpartum testing rates.  
Finally, additional efforts should be made to raise public awareness of long-term sequels 
of GD during pregnancy. 
 
Another important observation in this study was that women who develop diabetes after 
GD in pregnancy had higher pre pregnancy BMI compared with women who did not 
develop diabetes after GD in pregnancy. This is in accordance with previously published 
studies, such as the study by Albadera et al.  (9) where prepregnancy BMI was 
recognized as an important independent predictive factor for diabetes after GD in 
pregnancy. Considering this, preventive measures and education should be especially 
oriented toward obese women who develop GD during pregnancy. Median age of 
women with GD who developed diabetes was higher compared to women with GD who 
did not develop diabetes, but the result was not statistically significant. This result differs 
to results of other studies (11), and might be due to a small sample size presented in 
this study.  
 
Conclusions 
Women with a history of gestational diabetes represent a population at high risk for 
development of diabetes. This was reveled in this study where 3.75% of women with GD 
during pregnancy developed diabetes within 5 years after delivery. This group of women, 
and especially the subgroup with higher BMIs, should be recognized, followed up and 
target screened after delivery in order to identify the presence of diabetes in the earliest 
stage possible. Primary care practitioners play an essential role in this process with the 
aim of reducing the number of women developing diabetes early in life. 
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